Clinical Trial

Vaccine Pandemic Preparedness Through Airway Immunology Characterization

Study acronym: VAXXAIR
Active, Not Recruiting Early Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated March 25, 2026 (before its estimated July 27, 2026 completion). Its status may not reflect the trial's current state.
Summary
The study aims to compare the effectiveness of live attenuated influenza vaccines (LAIV) and intramuscular-inactivated vaccines (IIV) in healthy individuals aged 18-49. It will investigate cellular and humoral responses, identify immunological markers for targeted vaccine improvement, and establish a collaborative platform for accelerated immunological and clinical vaccine research.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-06-18; most recent amendment 2026-03-23.
Status change: Not Yet Recruiting → Active, Not Recruiting 2026-03-23
Trial Details
NCT Number NCT05921448
Lead Sponsor Copenhagen Respiratory Research
Collaborators: The Novo Nordic Foundation
Conditions Influenza, Human
Enrollment 60 participants
Start Date 2025-05-19
Primary Completion 2026-07-27 (estimated)
Study Completion 2026-07-27 (estimated)
Updated on ClinicalTrials.gov 2026-03-25